BioDelivery Sciences International Inc.

BioDelivery Sciences International is a pharmaceutical company with a focus on patients living with chronic pain. The company has built a portfolio of products utilizing its BioErodible MucoAdhesive drug delivery technology, and other drug-delivery technologies to develop and commercialize new applications of proven therapies aimed at addressing unmet medical needs. The company's product candidates include: BELBUCA for the management of pain severe enough to require long-term opioid treatment and for which alternative treatment options are inadequate; BUNAVAIL for the treatment of opioid dependence; and ONSOLIS/BREAKYL/PAINKYL for the treatment of breakthrough cancer pain in opioid tolerant patients.
  • TickerBDSI
  • ISINUS09060J1060
  • ExchangeNASDAQ Stock Market
  • SectorPharmaceuticals & Biotechnology
  • CountryUnited States

Analysts

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

Biodelivery Sciences International Inc: 1 director sold

A director at Biodelivery Sciences International Inc sold 50,000 shares at 6.360USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rule...

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

ValuEngine Rating and Forecast Report for BDSI

MarketLine Department

Assertio Therapeutics, Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Assertio Therapeutics, Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Assertio Therapeutics, Inc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competiti...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch